Recommendations for Assessment, Monitoring and Maintenance of Cognitive Health in MS

EP: 1.Disease Progression in Multiple Sclerosis (MS): Overview of Relapse-associated Worsening (RAW) and Progression Independent of Relapse Activity (PIRA) EP: 2.Impact of High Efficacy Therapies on Understanding of Disease Progression in MS EP: 3.Considerations for Comprehensive Patient Evaluation...

Full description

Saved in:
Bibliographic Details
Published inNeurology live (Print)
Main Author Hughes, Bruce
Format Journal Article
LanguageEnglish
Published Cranbury Intellisphere, LLC 16.11.2023
MultiMedia Healthcare Inc
Subjects
Care and treatment
Chemotherapy
Cognition & reasoning
Cognitive ability
Development and progression
Hughes, Bruce
Inflammation
Multiple sclerosis
Neurodegeneration
Neurology
Patients
Online AccessGet full text

Cover

More Information
Summary:EP: 1.Disease Progression in Multiple Sclerosis (MS): Overview of Relapse-associated Worsening (RAW) and Progression Independent of Relapse Activity (PIRA) EP: 2.Impact of High Efficacy Therapies on Understanding of Disease Progression in MS EP: 3.Considerations for Comprehensive Patient Evaluation and Switching to High-efficacy Therapies (HETs) Now Viewing EP: 4.Recommendations for Assessment, Monitoring and Maintenance of Cognitive Health in MS Bruce Hughes, MD: Short of that, [for the] monitoring of patients for providers who don't have easy access to repetitive neurological or psychological testing, what measures do you think clinicians can use that might give them some clues, aside from listening to the patient and family members, which I think is exceedingly important? Unlike the PASAT [paced auditory serial addition test], it isn't maddening to patients to do it. [...]it's really preventive care in terms of matching them up with the medicine that is going to serve them best.
ISSN:2767-4258
2767-4266